Tuberculosis-HIV Co-Infection: Progress and Challenges After Two Decades of Global Antiretroviral Treatment Roll-Out.
MetadataShow full item record
JournalArchivos de Bronconeumología
AbstractDespite wide antiretroviral scale-up during the past two decades resulting in declining new infections and mortality globally, HIV-associated tuberculosis remains as a major public health concern. Tuberculosis is the leading HIV-associated opportunistic infection and the main cause of death globally and, particularly, in resource-limited settings. Several challenges exist regarding diagnosis, global implementation of latent tuberculosis treatment, management of active tuberculosis, delivery of optimal patient-centered TB and HIV prevention and care in high burden countries. In this article we review the advances on pathogenesis, diagnosis, and treatment after nearly two decades of global roll-out of antiretroviral therapy and discuss the current challenges for the global control of tuberculosis-HIV co-infection.
- Authors: Bloom BR, Atun R, Cohen T, Dye C, Fraser H, Gomez GB, Knight G, Murray M, Nardell E, Rubin E, Salomon J, Vassall A, Volchenkov G, White R, Wilson D, Yadav P, Holmes KK, Bertozzi S, Bloom BR, Jha P
- Issue date: 2017 Nov 3
- Tuberculosis and HIV Coinfection.
- Authors: Bruchfeld J, Correia-Neves M, Källenius G
- Issue date: 2015 Feb 26
- A Markov model for the effects of virological failure on HIV/AIDS progression in tuberculosis co-infected patients receiving antiretroviral therapy in a rural clinic in northern South Africa.
- Authors: Shoko C, Chikobvu D, Bessong PO
- Issue date: 2020 Mar 30
- Tuberculosis treatment outcome and its associated factors among people living with HIV and AIDS in Fako Division of Cameroon.
- Authors: Tanue EA, Nsagha DS, Njamen TN, Assob NJC
- Issue date: 2019
- [Tuberculosis and HIV co-infection: a therapeutic challenge].
- Authors: Charbonnier F, Calmy A, Janssens JP
- Issue date: 2011 Nov 23